PMC:7200337 / 93794-93973 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T732","span":{"begin":86,"end":94},"obj":"Body_part"}],"attributes":[{"id":"A732","pred":"fma_id","subj":"T732","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Although results from the randomized trial are not yet published, anti-C5a monoclonal antibody therapy showed benefits in two critically ill COVID-19 patients (Gao et al., 2020d)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T535","span":{"begin":141,"end":149},"obj":"Disease"}],"attributes":[{"id":"A535","pred":"mondo_id","subj":"T535","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Although results from the randomized trial are not yet published, anti-C5a monoclonal antibody therapy showed benefits in two critically ill COVID-19 patients (Gao et al., 2020d)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3068","span":{"begin":71,"end":74},"obj":"Gene"},{"id":"3073","span":{"begin":150,"end":158},"obj":"Species"},{"id":"3076","span":{"begin":126,"end":140},"obj":"Disease"},{"id":"3077","span":{"begin":141,"end":149},"obj":"Disease"}],"attributes":[{"id":"A3068","pred":"tao:has_database_id","subj":"3068","obj":"Gene:728"},{"id":"A3073","pred":"tao:has_database_id","subj":"3073","obj":"Tax:9606"},{"id":"A3076","pred":"tao:has_database_id","subj":"3076","obj":"MESH:D016638"},{"id":"A3077","pred":"tao:has_database_id","subj":"3077","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Although results from the randomized trial are not yet published, anti-C5a monoclonal antibody therapy showed benefits in two critically ill COVID-19 patients (Gao et al., 2020d)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T539","span":{"begin":0,"end":179},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Although results from the randomized trial are not yet published, anti-C5a monoclonal antibody therapy showed benefits in two critically ill COVID-19 patients (Gao et al., 2020d)."}